Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

SELL
$32.09 - $37.51 $487,607 - $569,964
-15,195 Reduced 52.79%
13,589 $450,000
Q2 2023

Aug 07, 2023

SELL
$36.12 - $41.79 $18,565 - $21,480
-514 Reduced 1.75%
28,784 $1.06 Million
Q1 2023

Apr 21, 2023

BUY
$39.39 - $51.28 $157,953 - $205,632
4,010 Added 15.86%
29,298 $1.2 Million
Q4 2022

Jan 31, 2023

BUY
$41.75 - $54.5 $46,885 - $61,203
1,123 Added 4.65%
25,288 $1.3 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1.06 Million - $1.29 Million
24,165 New
24,165 $1.06 Million
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $957,639 - $1.19 Million
-20,932 Closed
0 $0
Q4 2021

May 16, 2022

BUY
$41.32 - $61.25 $80,739 - $119,682
1,954 Added 10.3%
20,932 $1.24 Million
Q4 2021

Feb 11, 2022

SELL
$41.32 - $61.25 $81,276 - $120,478
-1,967 Reduced 9.39%
18,978 $1.12 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $255,988 - $328,839
-6,522 Reduced 23.74%
20,945 $900,000
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $574,236 - $650,513
15,991 Added 139.34%
27,467 $1.08 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $384,331 - $433,448
11,476 New
11,476 $415,000
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $6.78 Million - $7.7 Million
-206,085 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $204,004 - $264,534
-6,279 Reduced 2.96%
206,085 $7.4 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $7.85 Million - $8.82 Million
212,364 New
212,364 $9.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Syntal Capital Partners, LLC Portfolio

Follow Syntal Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syntal Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syntal Capital Partners, LLC with notifications on news.